Five-year results confirm Roches Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma
Exploratory long-term follow-up analysis of the phase III POLARIX study indicated a…
Fobi AI Provides Clarification On Total Holdings Previously Provided In The Companys Information Circular
December 06, 2024 20:43 ET | Source: Fobi AI Inc. VANCOUVER, British…
Fobi AI Provides Clarification On Total Holdings Previously Provided In The Companys Information Circular
December 06, 2024 20:43 ET | Source: Fobi AI Inc. VANCOUVER, British…